PharmaCyte Biotech, Inc.
NASDAQ:PMCB
1.79 (USD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.012 | 0.067 | 0.126 | 0.263 | 0.653 | 1.19 | 1.17 | 0.537 | 0.086 | 0.002 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.019 | 0.032 | 0.229 | 0.427 | 0.266 | 0.171 | 0 | 0.041 | 0.001 | 0 | 0 |
| Gross Profit
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.003 | 0.047 | 0.094 | 0.034 | 0.226 | 0.924 | 0.999 | 0.537 | 0.045 | 0.002 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.209 | 0.709 | 0.745 | 0.13 | 0.346 | 0.776 | 0.854 | 1 | 0.521 | 0.673 | 0 | 0 |
| Reseach & Development Expenses
| 0.407 | 0.469 | 0.691 | 0.916 | 0.301 | 0.46 | 1.998 | 1.182 | 1.407 | 3.477 | 0 | 0 | 0 | 0.009 | 0.492 | 0.474 | 0.413 | 0.134 | 0.119 | 1.108 | 1.409 | 0 | 0 |
| General & Administrative Expenses
| 2.117 | 5.987 | 3.701 | 2.707 | 3.525 | 3.641 | 4.984 | 3.26 | 4.666 | 9.988 | 18.107 | 1.58 | 1.985 | 0.462 | 1.239 | 5.2 | 0 | 0 | 6.559 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 1.322 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.231 | 0.872 | 0.106 | 0.011 | 0.011 | 0.412 | 0.594 | 0 | 0 | 1.194 | 0 | 0 | 0 | 0 |
| SG&A
| 2.117 | 5.987 | 3.701 | 2.707 | 3.525 | 3.641 | 4.984 | 3.26 | 4.666 | 10.219 | 18.979 | 1.687 | 1.996 | 0.473 | 1.651 | 5.794 | 4.26 | 4.472 | 7.753 | 3.1 | 0.314 | 0.032 | 0 |
| Other Expenses
| 5.995 | 0.202 | -0.004 | -0.001 | -0 | 0.033 | 0.153 | 2.515 | 0.011 | 3.338 | -5.895 | 0.003 | 1.222 | 0.104 | 0 | 4.072 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 |
| Operating Expenses
| 8.52 | 6.455 | 4.392 | 3.623 | 3.826 | 4.101 | 6.981 | 4.442 | 6.073 | 13.695 | 18.979 | 1.687 | 1.996 | 0.482 | 2.143 | 6.268 | 4.673 | 4.606 | 7.872 | 4.208 | 1.722 | 0.032 | 0.03 |
| Operating Income
| -8.52 | -6.455 | -4.392 | -3.623 | -3.826 | -4.101 | -6.981 | -4.442 | -6.073 | -13.695 | -18.979 | -1.684 | -1.949 | -0.388 | -2.109 | -6.042 | -3.749 | -3.607 | -7.335 | -4.163 | -1.721 | -0.032 | -0.03 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -138.517 | -29.285 | -3.082 | -8.021 | -9.251 | -3.151 | -3.084 | -13.658 | -48.196 | -722.133 | 0 | 0 |
| Total Other Income Expenses Net
| 8.854 | 2.14 | 0.153 | 0.072 | -0 | 0.033 | 0.153 | -0.002 | 0.009 | 2.841 | -8.275 | 0.086 | 0.05 | -0.838 | -3.883 | 0 | -0.043 | -0.007 | -1.761 | -0.114 | 1.732 | 0 | 0 |
| Income Before Tax
| -17.237 | -4.316 | -4.239 | -3.551 | -3.827 | -4.067 | -6.829 | -4.444 | -6.064 | -10.855 | -27.254 | -1.598 | -1.658 | -1.226 | -5.699 | -6.029 | -3.815 | -3.601 | -9.033 | -4.148 | 0 | 0 | 0 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -131.423 | -24.912 | -9.731 | -21.676 | -9.231 | -3.206 | -3.079 | -16.821 | -48.019 | 0 | 0 | 0 |
| Income Tax Expense
| -6.52 | -1.937 | -0.153 | 0.003 | 0 | -0.033 | -0.153 | -0.004 | -0.005 | 0.005 | 0.02 | 0.154 | -0.05 | 1.009 | 3.883 | -0 | 0.043 | 0.007 | 2.05 | 0.114 | 1.725 | 0.032 | 0.03 |
| Net Income
| -17.237 | -4.316 | -4.086 | -3.554 | -3.827 | -4.067 | -6.829 | -4.444 | -6.064 | -10.855 | -27.254 | -1.598 | -1.899 | -1.398 | -5.992 | -6.042 | -3.792 | -3.614 | -9.385 | -4.277 | -1.725 | -0.032 | -0.03 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -131.423 | -28.536 | -11.093 | -22.789 | -9.25 | -3.187 | -3.09 | -17.476 | -49.516 | -723.758 | 0 | 0 |
| EPS
| -1.8 | -0.22 | -0.26 | -2.46 | -4.23 | -5.55 | -10.57 | -7.89 | -12.09 | -23.11 | -70.06 | -5.43 | -7.6 | -5.98 | -29.81 | -44.86 | -33.86 | -33.36 | -102.95 | -61.74 | -27.4 | -0.55 | -0.51 |
| EPS Diluted
| -1.8 | -0.22 | -0.26 | -2.46 | -4.23 | -5.55 | -10.57 | -7.88 | -12.08 | -23.11 | -70.06 | -5.43 | -7.6 | -5.98 | -29.81 | -44.86 | -33.86 | -33.36 | -102.95 | -61.74 | -27.4 | -0.55 | -0.51 |
| EBITDA
| 0.334 | 0 | 0 | 0 | -3.826 | 0 | 0 | -4.442 | 0 | -9.923 | -27.233 | -1.684 | -1.633 | -0.388 | -2.109 | -5.986 | -3.783 | -3.606 | -7.335 | -1.722 | -1.732 | -0.032 | -0.03 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -138.304 | -33.289 | 3.889 | 6.071 | -9.227 | -3.09 | -3.088 | -10.495 | -48.103 | -722.133 | 0 | 0 |